Download Files:
NAD+-13C5-1
SKU
HY-B0445S1-Get quote
Category Isotope-Labeled Compounds
Tags Endogenous Metabolite, Metabolic Disease, Metabolic Enzyme/Protease
Products Details
Product Description
– NAD+-13C5-1 is the 13C labeled NAD+[1]. NAD+ is a coenzyme composed of ribosylnicotinamide 5′-diphosphate coupled to adenosine 5′-phosphate by pyrophosphate linkage.
Web ID
– HY-B0445S1
Shipping
– Room temperature
Molecular Formula
– C16 13C5H27N7O14P2
References
– [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Viollet, B., et al., Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond), 2012. 122(6): p. 253-70.|[3]Brandt, U., Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem, 2006. 75: p. 69-92.|[4]Kussmaul, L. and J. Hirst, The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci U S A, 2006. 103(20): p. 7607-12.
CAS Number
– 1859096-06-2
Molecular Weight
– 668.39
SMILES
– O[C@H]1[C@](O[C@@H]([C@H]1O)COP(OP(O[13CH2][13C@H]2O[13C@]([N+]3=CC=CC(C(N)=O)=C3)([H])[13C@@H]([13C@@H]2O)O)([O-])=O)(O)=O)([H])N4C5=NC=NC(N)=C5N=C4
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– 10 mM in DMSO
Target
– Endogenous Metabolite
Pathway
– Metabolic Enzyme/Protease
Product type
– Isotope-Labeled Compounds
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.